Dental Membrane and Bone Graft Substitute Market Revenue by 2026 | Citagenix Inc, Straumann AG, Geistlich, Dentsply International, Zimmer Biomet, Medtronic Plc., BioHorizons IPH, Inc., ACE Surgical Supply Company, Inc., RTI Surgical

In order to fulfil this needs market players are launching a wide variety of bone grafting solution. For instance, in 2012 BioHorizons, Inc. launched MinerOss Cancellous, a mineralized cancellous bone allograft. MinerOss Cancellous promote rapid revascularization and gives predictable results. Moreover, in 2014, Geistlich Pharma AG received Therapeutic Goods Administration (TGA) approval for Bio-Oss in Australia. Bio-Oss particles serve as a scaffold for new bone and results in predictable bone regeneration and significantly improves clinical attachment gain and pocket depth reduction in periodontal surgery.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1143

Furthermore, in 2011, in Japan, company received marketing authorization for Geistlich Bio-Oss. The strategic geographical expansion through the new launches is expected to result into the rapid growth of Asia Pacific region, which in turn is expected to fuel the growth of dental membrane and bone graft substitute market over the forecast period.
Gum disease and cavities are the common chronic disease seen in people of age 65 and above. Moderate to severe gum disease occurs in more than 60% of people over age 65. According to the Centers for Disease Control and Prevention (CDC), in 2010, an estimated around 48% i.e. around 64 million adults in the U.S. had periodontal disease.

Bone loss can be prevented by replacing single teeth with dental implant. In case of dental bone is lost, bone grafting is done to build a foundation for dental implants site.
According to Centers for Disease Control (CDC) NHANES Study, in 2016, the U.S. had more than 120 million people with one teeth missing and about 35 million people (i.e. approximately 10% of U.S. population) with all of their teeth missing in one or both jaws. American College of Prosthodontics (ACP) expects this number to further increase in next two decades. Increasing population with missing one or more teeth is expected to drive the growth of dental bone graft substitutes market. Moreover, increasing dentist population and growing awareness about dental procedures are expected to support the market growth in near future.

Some of the major players operating in the dental membrane and bone graft substitute market include Citagenix Inc, Straumann AG, Geistlich, Dentsply International, Zimmer Biomet, Medtronic Plc., BioHorizons IPH, Inc., ACE Surgical Supply Company, Inc., RTI Surgical, Inc., and Osteogenics Biomedical.

Request Sample copy of Report: https://www.coherentmarketinsights.com/insight/request-sample/1143

Detailed Segmentation:

Global Dental Membrane And Bone Graft Substitute Market, By Product Type:
Dental Membrane
Resorbable Membranes
Non - Resorbable Membranes
Bone Graft Substitute
Demineralized Bone Matrix (DBM)
Allograft
Xenograft
Synthetic Bone Graft Substitute
Global Dental Membrane And Bone Graft Substitute Market, By Material:
Hydrogel
Collagen
Human Cell Source
Other Species
Hydroxyapatite
Tricalcium Phosphate
Polytetrafluoroethylene
Global Dental Membrane And Bone Graft Substitute Market, By End User:
Hospitals
Dental Clinics
Ambulatory Surgical Center

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.